Cdkn2a - cyclin-dependent kinase inhibitor 2A Gene
Also Known as Arf; p16; MTS1; INK4A; p19ARF; p16Cdkn2a
Species: Rattus norvegicus
Summary
Predicted to enable several functions, including MDM2/MDM4 family protein binding activity; NF-kappaB binding activity; and enzyme inhibitor activity. Involved in several processes, including cellular response to glucose stimulus; negative regulation of hepatocyte proliferation; and nervous system development. Located in cytoplasm and nucleus. Used to study carcinoma (multiple); endometrial cancer; pre-malignant neoplasm; rhabdomyosarcoma; and sarcomatoid mesothelioma. Biomarker of hepatocellular carcinoma; hypertension; obesity; and osteoarthritis. Human ortholog(s) of this gene implicated in several diseases, including breast Cancer (multiple); hematologic Cancer (multiple); melanoma (multiple); nervous system Cancer (multiple); and pancreatic Cancer (multiple). Orthologous to human CDKN2A (cyclin dependent kinase inhibitor 2A). [provided by Alliance of Genome Resources, Apr 2022]
Cdkn2a Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_031550.2 | NP_113738.1 | cyclin-dependent kinase inhibitor 2A |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cyclin-dependent kinase inhibitor 2A |
|
|